Sclerosteosis
What is Sclerosteosis?
Sclerosteosis is a rare genetic condition that causes excessive bone growth throughout the body. This disorder happens when mutations occur in the SOST gene, which normally helps control how much bone your body makes. When this gene does not work properly, bones become too thick and dense.
The condition is inherited in an autosomal recessive pattern. This means a person must inherit two copies of the mutated gene, one from each parent, to develop the condition. People with sclerosteosis often have very tall stature and distinctive facial features due to abnormal bone growth in the skull and face.
Sclerosteosis is extremely rare, with most cases reported in the Afrikaner population of South Africa. The excessive bone growth can put pressure on nerves and reduce the space inside the skull. This can lead to serious complications if not monitored carefully by medical professionals.
Symptoms
- Unusually tall stature and large body frame
- Broad, square jaw and prominent forehead
- Fused or missing finger bones, especially in the middle fingers
- Facial paralysis or weakness due to nerve compression
- Hearing loss from bone growth in the ear canals
- Headaches and increased pressure inside the skull
- Vision problems if bone growth affects the optic nerve
- Difficulty with hand movements and grip strength
Symptoms typically appear in childhood as bones grow and thicken. Some people may have mild cases with fewer complications. Early detection helps doctors monitor bone growth and prevent nerve damage before it becomes severe.
Concerned about Sclerosteosis? Check your levels.
Screen for 1,200+ health conditions
Causes and risk factors
Sclerosteosis is caused by mutations in the SOST gene, which provides instructions for making a protein called sclerostin. This protein normally acts as a brake on bone formation, keeping bone growth balanced. When the gene is mutated, the body cannot make working sclerostin, so bones keep growing thicker without the usual controls. The condition is inherited when both parents carry one copy of the mutated gene and pass it to their child.
There are no lifestyle or environmental risk factors for sclerosteosis because it is purely genetic. The main risk factor is having parents who both carry the SOST gene mutation. Genetic counseling can help families understand their risk if they have a family history of the condition or come from populations where it is more common.
How it's diagnosed
Sclerosteosis is diagnosed through a combination of physical examination, imaging studies, and genetic testing. Doctors look for characteristic features like unusually dense bones on X-rays and CT scans. Bone density scans show much higher readings than normal. Genetic testing confirms the diagnosis by identifying mutations in the SOST gene.
Some research has explored LRP4 antibodies in relation to bone formation pathways, though this is not a standard diagnostic test for sclerosteosis. Specialized genetic testing is needed to confirm this condition. Talk to our medical team about testing options and getting connected with genetic specialists who can provide the right diagnostic workup.
Treatment options
- Surgical decompression to relieve pressure on nerves, especially facial and auditory nerves
- Hearing aids or cochlear implants if hearing loss occurs
- Physical therapy to maintain hand function and mobility
- Regular monitoring with imaging studies to track bone growth
- Pain management for headaches and bone-related discomfort
- Surgery to address facial bone overgrowth if needed
- Genetic counseling for family planning decisions
There is currently no cure for sclerosteosis, so treatment focuses on managing symptoms and preventing complications. Early intervention with surgery can prevent permanent nerve damage. Regular follow-up with specialists in genetics, neurology, and orthopedics helps ensure the best outcomes.
Frequently asked questions
Sclerosteosis causes excessive bone growth throughout the entire body, unlike conditions that affect only specific bones. It is caused by a specific genetic mutation in the SOST gene. The condition is much rarer than other bone disorders like osteopetrosis or Van Buchem disease, though it shares some similarities with the latter.
Yes, if both parents are known carriers of the SOST gene mutation, prenatal genetic testing can detect sclerosteosis. This testing is done through amniocentesis or chorionic villus sampling. Families with a history of the condition often choose prenatal testing to prepare for specialized care if needed.
Pain is not always a primary symptom, but headaches can occur due to increased pressure inside the skull. Nerve compression may cause discomfort or facial pain. Some people experience bone pain as the excessive growth puts stress on joints and surrounding tissues.
Sclerosteosis follows an autosomal recessive inheritance pattern. This means both parents must carry one copy of the mutated SOST gene. Each child of two carriers has a 25% chance of having the condition, a 50% chance of being a carrier, and a 25% chance of inheriting two normal genes.
Because sclerosteosis is purely genetic, lifestyle changes cannot stop or reverse bone growth. However, staying active with physical therapy helps maintain mobility and hand function. Regular medical monitoring and early surgical intervention remain the most important management strategies.
Untreated sclerosteosis can lead to permanent facial paralysis, complete hearing loss, and vision loss. Excessive bone growth in the skull can increase pressure on the brain, causing severe headaches and neurological problems. Early surgical intervention prevents many of these complications from becoming permanent.
Sclerosteosis is extremely rare worldwide, with most cases found in the Afrikaner population of South Africa. Fewer than 100 cases have been reported in medical literature. The carrier rate is higher in certain populations due to founder effects, where the mutation was passed down through specific family lines.
Standard blood tests cannot diagnose sclerosteosis directly. Genetic testing through blood samples can identify SOST gene mutations. Some research has looked at LRP4 antibodies in bone formation, but genetic testing remains the gold standard for confirming this diagnosis.
Research into sclerostin biology has led to the development of drugs that block sclerostin for osteoporosis treatment. Ironically, people with sclerosteosis lack sclerostin naturally. Currently, no gene therapy or targeted treatments are available, but research continues into managing excessive bone formation.
Yes, siblings and close relatives should consider genetic testing to determine if they are carriers. This information is valuable for family planning decisions. Genetic counseling helps families understand inheritance patterns and testing options for current and future generations.